ArticleJournal of pharmacological sciences2026
Sodium-glucose Co-transporter 2 (SGLT2) inhibitor dapagliflozin acutely activates cardiomyocyte HIF-1α signaling via succinate, a signaling metabolite.
Tatsuyuki Sato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.